Home › Neoplasie del sangue › California

Studi clinici su Neoplasie del sangue nello stato di California

35 studi su Neoplasie del sangue cercano partecipanti presso sedi nello stato di California.

Città nello stato di California

Testo ufficiale dello studio (inglese)

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Comprehensive Blood & Cancer Center [Bakersfield, CA] ( Site 0054), Bakersfield
UCLA - Hematology/Oncology - Administrative Office ( Site 0009), Los Angeles
Stanford Cancer Center ( Site 0086), Palo Alto
e altri 2

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT03486873

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
PCR Oncology, Arroyo Grande
AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
e altri 20

In reclutamentoStudio osservazionaleVolontari sani benvenuti

Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05334069

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

University of California San Diego Moores Cancer Center ( Site 2717), La Jolla

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 24 set 2026 · NCT04728893

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Quetzal Site 1, Duarte
Quetzal Site 7, Los Angeles
Quetzal Site 5, Stanford

In reclutamentoFase 3

Età da 18 a 71 · Tutti i sessi · Aggiornato il 23 set 2026 · NCT07504458

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

University of California Davis Comprehensive Cancer Center, Sacramento

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT03816345

Wearable Activity Tracking to Curb Hospitalizations

University of California, San Francisco, San Francisco

In reclutamentoStudio osservazionale

Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT06587100

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

UC Irvine, Orange

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 21 set 2026 · NCT07648264

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

PCR Oncology, Arroyo Grande
Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank
Washington Health, Fremont
e altri 3

In reclutamentoStudio osservazionale

Tutte le età · Tutti i sessi · Aggiornato il 17 set 2026 · NCT04242095

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

City of Hope Comprehensive Cancer Center, Duarte
UCLA Medical Center, Los Angeles
Stanford Cancer Institute, Stanford

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 15 set 2026 · NCT04996875

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

City of Hope Medical Center, Duarte
University of California San Diego Medical Center, Moores Cancer Center, La Jolla

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 15 set 2026 · NCT07195916

M-2018-334 in Hematological Malignancies

City of Hope, Duarte

In reclutamento

Età da 18 a 75 · Tutti i sessi · Aggiornato il 11 set 2026 · NCT06225050

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

City of Hope, Duarte

In reclutamentoFase 1/2Volontari sani benvenuti

Età da 12 a 120 · Tutti i sessi · Aggiornato il 11 set 2026 · NCT05436418

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

City of Hope National Medical Center, Duarte

In reclutamentoFase 1/2

Età 12 e oltre · Tutti i sessi · Aggiornato il 3 set 2026 · NCT04588922

Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy

City of Hope Medical Center, Duarte

In reclutamentoFase 3Volontari sani benvenuti

Età 18 e oltre · Tutti i sessi · Aggiornato il 28 ago 2026 · NCT07186192

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

University of California, Fresno, Clovis
University of California, San Diego, La Jolla
Cedars-Sinai Medical Center, Los Angeles
e altri 2

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

USC Norris Comprehensive Cancer Center, Los Angeles
UCLA Health - Bowyer Oncology Center, Los Angeles
UC Irvine Health Chao Family Comprehensive Cancer Center, Orange
e altri 1

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT06001788

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies

Cedars-Sinai Medical Center, Los Angeles

In reclutamentoFase 1

Età da 18 a 85 · Tutti i sessi · Aggiornato il 10 ago 2026 · NCT05887167

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

City Of Hope, Duarte
University of California, Los Angeles

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 10 ago 2026 · NCT06823167

Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant

Cedars-Sinai Medical Center, Los Angeles

In reclutamentoFase 1

Età 65 e oltre · Tutti i sessi · Aggiornato il 5 ago 2026 · NCT05849207

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

City of Hope National Medical Center, Duarte

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 4 ago 2026 · NCT06665100

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

START Los Angele, Los Angeles

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 30 lug 2026 · NCT07424833

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

UCLA Department of Medicine, Los Angeles

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 7 lug 2026 · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

City of Hope, Duarte
Children's Hospital of Los Angeles, Glendale
Scripps Green Hospital, La Jolla
e altri 8

In reclutamentoStudio osservazionale

Tutte le età · Tutti i sessi · Aggiornato il 6 lug 2026 · NCT01351545

IVIG for Infection Prevention After CAR-T-Cell Therapy

City of Hope Cancer Center, Duarte

In reclutamentoFase 2

Età 18 e oltre · Tutti i sessi · Aggiornato il 29 giu 2026 · NCT05952804

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

University of California LA, Los Angeles

In reclutamentoFase 3

Età 18 e oltre · Tutti i sessi · Aggiornato il 11 giu 2026 · NCT06401356

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

UC San Diego Moores Cancer Center, La Jolla
University of California, San Francisco, San Francisco

In reclutamentoStudio osservazionale

Età 18 e oltre · Tutti i sessi · Aggiornato il 1 giu 2026 · NCT05663502

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

UCSF Benioff Children's Hospital Oakland, Oakland
UCSF Medical Center-Mission Bay, San Francisco

In reclutamentoFase 3

Età da 2 a 18 · Tutti i sessi · Aggiornato il 5 mag 2026 · NCT05711667

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

City of Hope, Duarte
Providence St. John's Health Center, Santa Monica

In reclutamentoFase 1/2

Età 18 e oltre · Tutti i sessi · Aggiornato il 16 apr 2026 · NCT03328078

Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

USC / Norris Comprehensive Cancer Center, Los Angeles

In reclutamentoStudio osservazionaleVolontari sani benvenuti

Età 19 e oltre · Tutti i sessi · Aggiornato il 2 apr 2026 · NCT03207854

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Moores UC San Diego Cancer Center, La Jolla
USC / Norris Comprehensive Cancer Center, Los Angeles
UCLA - Bowyer Oncology Center, Los Angeles
e altri 1

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 13 mar 2026 · NCT05735184

Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation

Chao Family Comprehensive Cancer Center, University of California Irvine, Orange

In reclutamentoFase 2

Età da 18 a 70 · Tutti i sessi · Aggiornato il 2 feb 2026 · NCT06028828

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

University of Southern California - Norris Comprehensive Cancer Center, Los Angeles

In reclutamentoStudio osservazionale

Età 18 e oltre · Tutti i sessi · Aggiornato il 25 giu 2025 · NCT05768269

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

Valkyrie Clinical Trials, Los Angeles

In reclutamentoFase 1/2

Età 18 e oltre · Tutti i sessi · Aggiornato il 3 giu 2025 · NCT06119685

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

City of Hope, Duarte

In reclutamentoFase 1

Età 18 e oltre · Tutti i sessi · Aggiornato il 15 apr 2025 · NCT06462365

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Children's Hospital Los Angeles, Los Angeles
Children's Hospital Orange County, Orange
UCSF School of Medicine, San Francisco

In reclutamentoFase 1

Età da 1 a 21 · Tutti i sessi · Aggiornato il 6 dic 2024 · NCT05476770

Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.